TGen News & Press Releases

Genome sequencing identifies factors that cause resistance to multiple myeloma T cell therapies

Posted Thursday August 31, 2023

Study suggests the problem is more common than previously thought

Study Links Inherited Mutations to Okur-Chung Neurodevelopmental Syndrome

Posted Wednesday August 16, 2023

HELIOS SCHOLARS AT TGEN CELEBRATE 17th ANNUAL SUMMER OF SCIENCE

Posted Thursday July 27, 2023

Interns Showcase Work at Day-Long Scientific Symposium

TGen appoints J. Gregory Caporaso, Ph.D., Professor in its Pathogen and Microbiome Division

Posted Tuesday July 25, 2023

Erroneous genetic sequences identified for the first time in specific cells of ALS and frontotemporal dementia patients

Posted Wednesday July 19, 2023

Gene splicing defect known as “cryptic exons” detected using single-nuclei RNA sequencing

Novel Genetic Sequencing Technology Helps Researchers Find Answers in Cases of Pediatric Rare Disorders

Posted Monday July 10, 2023

The study identified likely cause of genetic disorder in six families

Single-Cell Atlas of the Whole Human Lung

Posted Thursday June 8, 2023

First integrated Human Lung Cell Atlas provides insights into lung diseases

ATLANTA NON-PROFIT, PURPLE PANSIES, DONATES $726,000 IN SUPPORT OF TGEN CLINICAL STUDY

Posted Tuesday May 23, 2023

TGen recognizes Valley leader, William Post, and Atlanta restauranteur, Maria Fundora, at its annual Founders Dinner

Posted Tuesday May 2, 2023

Awards recognize sustained commitment to furthering research and precision medicine

Genomic sequencing shows promise in preparation for emerging disease outbreaks

Posted Monday May 1, 2023

TGen scientists test new NGS technologies for utility in large-scale pandemic responses

Prev
[1]
2
3
4
5
Next

Media Contact

Galen Perry
[email protected]
602-343-8423

Newsletter

News Archive

View Media Release Archive

OnCline

TGen is a partner with OncLive

2023 © All Rights Reserved TGen. Registered 501(c)(3). EIN: 75-3065445